Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation
- 1 April 2007
- journal article
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 34 (4) , 551-561
- https://doi.org/10.1016/j.mcn.2006.12.005
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cannabinoid Receptor Type 1 Located on Presynaptic Terminals of Principal Neurons in the Forebrain Controls Glutamatergic Synaptic TransmissionJournal of Neuroscience, 2006
- Molecular Mechanisms of Cannabinoid Protection from Neuronal ExcitotoxicityMolecular Pharmacology, 2006
- Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosisThe FASEB Journal, 2005
- Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's diseaseNeurobiology of Disease, 2005
- Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signalingMolecular and Cellular Neuroscience, 2004
- Cholinergic elements in the zebrafish central nervous system: Histochemical and immunohistochemical analysisJournal of Comparative Neurology, 2004
- Smad3-Dependent Induction of Plasminogen Activator Inhibitor-1 in Astrocytes Mediates Neuroprotective Activity of Transforming Growth Factor-β1 against NMDA-Induced NecrosisMolecular and Cellular Neuroscience, 2002
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- Excitotoxic cell deathJournal of Neurobiology, 1992